Glucocorticoid receptor–Mineralocorticoid receptor heteromer interface (GR-MR heteromer interface)

The Glucocorticoid receptor–Mineralocorticoid receptor (GR-MR) heteromer interface is a specific protein-protein interaction site formed when the glucocorticoid receptor (NR3C1) and the mineralocorticoid receptor (NR3C2) associate to form a functional heterodimeric transcription factor (UniProt P04150, P08235). This interface is primarily located within the DNA-binding domains (DBD) and ligand-binding domains (LBD) of the receptors, allowing them to cooperatively bind to glucocorticoid response elements (GREs) in the promoter regions of target genes (PubMed: 10449055). In the central nervous system, particularly the hippocampus, the formation of these heteromers is essential for the biphasic response to stress hormones, where MRs mediate basal activity and GRs mediate the recovery phase (PubMed: 21664330). Dysregulation of the GR-MR interaction or an imbalance in their expression levels is a hallmark of stress-related pathologies, including major depressive disorder and chronic anxiety (PubMed: 27153545). While most current pharmacological agents are ligands that bind to the individual receptors (e.g., dexamethasone or spironolactone), the heteromer interface itself is an attractive target for developing dimer-specific modulators that could provide more precise control over corticosteroid signaling (PubMed: 24560090). Such therapeutic strategies aim to restore the physiological balance of the HPA axis while minimizing the systemic side effects associated with broad GR or MR activation or inhibition.

Other names

GR-MR heterodimer interfaceNR3C1-NR3C2 heteromer interfaceGlucocorticoid-mineralocorticoid receptor complex interfaceNR3C1-NR3C2 heterodimer

Modulation of the physical interaction between GR and MR subunits to selectively alter the transcriptional profile of target genes containing glucocorticoid response elements (GREs).